Multidisciplinary Study of Right Ventricular Dysplasia
Completed
Conditions studied: Heart Diseases, Arrhythmogenic Right Ventricular Dysplasia
In brief
The purpose of this study is to investigate the cardiac, clinical, and genetic aspects of arrhythmogenic right ventricular dysplasia (ARVD), a progressive disorder that predominantly affects the right side of the heart and causes ventricular arrhythmias.
Key facts
- Study ID
- NCT00024505
- Run by
- University of Arizona
- People needed
- 320
- Starts
- 2001-09-01
- Expected to finish
- 2010-07-01
- Last updated by the study team
- 2013-01-17
Who can join
Age: 12 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Males and females over the age of puberty
- Suspected ARVD based on the presence of major or minor Task Force Criteria
You may not qualify if…
- Children younger than 12 years of age
- Internal cardioverter defibrillator (ICD) in place for more than 2 years (for probands)
- Individuals with monomorphic ventricular ectopy of predominantly RBBB morphology
- Individuals with obvious cardiomyopathic abnormalities of structure or function predominantly affecting the left ventricle
- Individuals with other conditions that might be mistaken for right ventricular dysplasia such as congenital heart disease, e.g., atrial septal defect, anomalous drainage of the pulmonary vessels into the right atrium, and Ebstein's malformation
- Individuals unwilling to undergo diagnostic testing at the nearest enrolling center
Where it is running
- University of Arizona — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.